Clindamycin Phosphate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Clindamycin Phosphate Injection (injection) from Pfizer Inc. with status To Be Discontinued. The shortage was first posted on 06/01/2026.
Shortage Details
- Status
- To Be Discontinued
- Company
- Pfizer Inc.
- Package NDC
- 0009-0870-26
- Dosage Form
- Injection
- Presentation
- Cleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL); 2 mL Vial (NDC 0009-0870-26)
- Initial Posting
- 06/01/2026
- Revised Date